Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies
Date
2010
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Wischik, C M, Wischik, D J, Storey, J M D & Harrington, C R 2010, Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies. in A Martinez (ed.), Emerging drugs and targets for Alzheimer's disease : Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism. vol. 1, RSC Drug Discovery Series, Cambridge, pp. 210-232. https://doi.org/10.1039/9781849731065